Description: OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.
Home Page: www.optibiotix.com
Innovation Centre
York,
YO10 5DG
United Kingdom
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Stephen Patrick O'Hara | Founder, CEO & Exec. Director |
| Dr. Sofia Kolyda | Exec. Director of R&D and Exec. Director |
| Mr. Rene Kamminga | CEO of Functional Fibres & Director |
| Mr. Mark Kingsley Collingbourne | CFO & Sec. |
| Paul Cannings | Head of Operations & Quality |
| Kevin James Newman | Corp. Devel. Director |
| Mr. Karl Burkitt | Marketing Director |
Exchange: OTCGREY
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | November |
| Full Time Employees: | 12 |